| Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients JL Revuelta-Herrero, E Chamorro-de-Vega, CG Rodríguez-González, ... Annals of Pharmacotherapy 52 (1), 11-18, 2018 | 65 | 2018 |
| Chimeric antigen receptor T cell therapy management and safety: a practical tool from a multidisciplinary team perspective MB Marzal-Alfaro, V Escudero-Vilaplana, JL Revuelta-Herrero, ... Frontiers in Oncology 11, 636068, 2021 | 14 | 2021 |
| Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain E Chamorro-de-Vega, CG Rodriguez-Gonzalez, S Manrique-Rodríguez, ... Expert review of clinical pharmacology 14 (2), 249-260, 2021 | 9 | 2021 |
| Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety MB Marzal-Alfaro, CG Rodriguez-Gonzalez, V Escudero-Vilaplana, ... Health informatics journal 26 (3), 1995-2010, 2020 | 8 | 2020 |
| Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease A Melgarejo-Ortuño, V Escudero-Vilaplana, JL Revuelta-Herrero, ... Journal of Oncology Pharmacy Practice 27 (3), 751-755, 2021 | 7 | 2021 |
| Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents V Escudero-Vilaplana, R Collado-Borrell, P Gómez Martínez-Sagrera, ... Journal of Cancer Research and Clinical Oncology, 1-28, 2022 | 5 | 2022 |
| DD-014 Staff satisfaction after the implementation of a robotic dispensing system in an outpatient pharmacy CG Rodriguez-Gonzalez, A Herranz-Alonso, A Gimenez-Manzorro, ... European Journal of Hospital Pharmacy 23 (Suppl 1), A110-A111, 2016 | 5 | 2016 |
| Medication guide for the perioperative management of oral antineoplastic agents in cancer patients C Villanueva-Bueno, V Escudero-Vilaplana, R Collado-Borrell, ... Expert Opinion on Drug Safety 21 (1), 107-119, 2022 | 3 | 2022 |
| Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice V Escudero-Vilaplana, JL Revuelta-Herrero, R Collado-Borrell, ... Expert opinion on drug safety 18 (9), 861-868, 2019 | 3 | 2019 |
| Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice JL Revuelta‐Herrero, A Giménez‐Manzorro, A Matilla‐Peña, ... Journal of clinical pharmacy and therapeutics 43 (6), 906-909, 2018 | 3 | 2018 |
| Implantación de una metodología para evaluar patient-reported outcomes en pacientes con cáncer de pulmón: protocolo del estudio PeOpLe (Patient-reported Outcomes in Lung cancer) C Villanueva-Bueno, R Collado-Borrell, JL Revuelta-Herrero, ... Farmacia Hospitalaria 46 (4), 265-269, 2022 | 2 | 2022 |
| Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer … V Escudero-Vilaplana, L Romero-Medrano, C Villanueva-Bueno, ... Frontiers in Oncology 12, 2022 | 2 | 2022 |
| A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application S García-Sánchez, R Collado-Borrell, E González-Haba, ... Frontiers in Oncology 12, 2022 | 2 | 2022 |
| DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach P Villalvazo, B Marzal-Alfaro, P García-Alfonso, JL Revuelta-Herrero, ... Journal of Personalized Medicine 11 (8), 792, 2021 | 2 | 2021 |
| Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia JL Revuelta-Herrero, R García-Sánchez, J Anguita-Velasco, ... International journal of clinical pharmacy 41 (5), 1143-1147, 2019 | 2 | 2019 |
| Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients J Vicente-Valor, V Escudero-Vilaplana, R Collado-Borrell, C López-López, ... Journal of Oncology Pharmacy Practice, 10781552221074621, 2022 | 1 | 2022 |
| A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital C Villanueva-Bueno, R Collado-Borrell, V Escudero-Vilaplana, ... Frontiers in Public Health 10, 2022 | 1 | 2022 |
| 5PSQ-078 Secukinumab for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in clinical practice EG Martín, R Romero-Jiménez, A Ais-Larisgoitia, V Escudero-Vilaplana, ... European Journal of Hospital Pharmacy 25 (Suppl 1), A200-A201, 2018 | 1 | 2018 |
| PP-026 Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report EG Martín, MSP López, B Monje, PAM Ortega, CO Navarro, JL Revuelta, ... Eur J Hosp Pharm 24 (Suppl 1), A213-A213, 2017 | 1* | 2017 |
| DI-053 Adherence, quality of life and patient satisfaction with dalfampridine in clinical practice BM Alfaro, ML Martin-Barbero, A Ribed, JL Revuelta, M Tovar-Pozo, ... European Journal of Hospital Pharmacy 23 (Suppl 1), A141-A141, 2016 | 1 | 2016 |
